IMNN Continues Phase 3 Study
IMUNON's Data Monitoring Committee recommends continuation of Phase 3 OVATION 3 Study without modification
IMNN - IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification